Inactivation of the neurofibromatosis type 2 (NF2) tumor suppressor gene function has been observed not only in familial schwannomas and other central nervous system tumors, but also in malignant tumors unrelated to the NF2 syndrome, indicating a broader role of NF2 in human tumorigenesis. The NF2-encoded protein Merlin is closely related to the Ezrin-Radixin-Moesin family of membrane/ cytoskeleton linker proteins, and has been demonstrated to suppress tumor growth by inhibiting extracellular signal-regulated kinase (ERK) and Rac1 activation. Interestingly, serum deprivation has been shown to regulate Merlin at the protein level, however, exactly how such condition affects Merlin remains elusive. In this study, we provide evidence to show that Merlin is regulated in a Roc1-Cullin4A-DDB1-dependent manner. Following serum stimulation, Merlin is recruited to the E3 ligase complex through a direct interaction with the WD40-containing adaptor protein VprBP. Loading of Merlin to the E3 ubiquitin ligase complex resulted in its polyubiquitination, and consequently its proteasomemediated degradation. Consistently, VprBP depletion abolished the in vivo interaction of Merlin and Roc1-Cullin4A-DDB1, which resulted in Merlin stabilization and inhibited ERK and Rac activation. Together, our data revealed a novel regulatory mechanism for the tumor suppressor function of Merlin.
Introduction
Inactivation of the neurofibromatosis type 2 (NF2) tumor suppressor gene leads to the development of several types of tumors commonly found in the central nervous system (CNS), in particular, meningiomas and schwannomas (Gutmann, 1997) . The NF2 gene encodes a 595 amino-acid protein Merlin (schwannomin), which is related to the Ezrin-Radixin-Moesin (ERM) protein family and was hence dubbed Merlin for Moesin, Ezrin, Radixin-like protein (Rouleau et al., 1993; Trofatter et al., 1993) . Merlin is putative tumor suppressor that is anchored at cell membrane where it links transmembrane receptors to the actin cytoskeleton (Xu and Gutmann, 1998; den Bakker et al., 2000) . Merlin can form homo-and heterotypic interactions which in turn regulate its binding to other proteins. Unlike Merlin in an open conformation, head-to-tail binding of Merlin, which leads to a closed conformation, is thought to act as a tumor suppressor and regulates cell growth (Gonzalez-Agosti et al., 1999; Bretscher et al., 2000) . Phosphorylation of a C-terminal serine (S518) by p21-activated kinase (PAK)-or cAMP-dependent protein kinase A weakens Merlin's self-association and is believed to inactivate its growth-suppressing activity. On the other hand, the phosphatase MYPT-1-PP1-d activates the tumor suppression activity of Merlin through S518 dephosphorylation, which subsequently inhibits the Ras/ERK (extracellular signal-regulated kinase) pathway (Shaw et al., 2001; Alfthan et al., 2004; Jin et al., 2006a) . In addition, Merlin can also be regulated at the protein level by growth arrest stimuli. Under conditions of serum deprivation, Merlin protein level increases significantly (Shaw et al., 1998; Lee et al., 2006) . However, the mechanism underlying the regulation of Merlin stability under such condition is not well understood.
The Roc1-CUL4-DDB1 ubiquitin E3 complex is a new class of cullin-containing ubiquitin E3 ligases. The Cullin E3 ligases have been shown to target a number of proteins for ubiquitination-dependent proteolysis via different adaptor proteins that afford specific substrate recognition (Higa and Zhang, 2007; Lee and Zhou, 2007) . Recently, multiple WD40 domain-containing proteins were found to interact with DDB1 and serve as the substrate-recognition subunits of the CUL4-DDB1 ubiquitin ligase complex (Angers et al., 2006; He et al., 2006; Higa et al., 2006; Jin et al., 2006b) . One of these WD40 domain-containing proteins, VprBP/ DCAF1, contains four WD40 domains and a LisH domain. VprBP was originally identified due to its interaction with the Vpr protein from the human immunodeficiency virus, however, the physiological function and substrates of VprBP/DCAF1 are still unknown (Zhang et al., 2001; Belzile et al., 2007; Hrecka et al., 2007; Le Rouzic et al., 2007; Tan et al., 2007; Wen et al., 2007) .
In this study, using a tandem affinity-purification approach, we have identified VprBP and DDB1 as two major binding partners of Merlin. Our data show that the Roc1-Cul4A-DDB1 E3 ligase complex controls the stability of Merlin, which in turn regulates ERK and Rac activities. Merlin is recruited to the E3 ligase through VprBP, where it is polyubiquitinated and targeted for proteasome-dependent degradation. We propose that the ubiquitination-dependent proteolysis of Merlin provides a fine-tune mechanism for its tumor suppressor activity.
Results

Identification of VprBP and DDB1 as Merlin-associated proteins
To identify Merlin-associated proteins, we purified Merlin-containing complex from human embryonic kidney 293T cells stably expressing full-length Merlin with an N-terminal triple tag that consists an S tag, a Flag epitope and a streptavidin-binding peptide (S-Flag-SBP (SFB)-Merlin). Two major protein bands, sizes of approximately 130 and 170 kDa, were co-purified with SFB-Merlin. Mass spectrometry analysis revealed these proteins as DDB1 and VprBP, respectively (Figure 1a ). VprBP and DDB1 have been shown to assemble with Cul4A and Roc1 to form an E3 ubiquitin ligase complex (Angers et al., 2006; He et al., 2006; Higa et al., 2006; Jin et al., 2006b ). In addition, several peptides derived from DDA1, an additional component of the Cul4A ligase complex, were also identified from the purification (Table 1) . Since VprBP has been speculated to serve as a substrate-recognition subunit of the Cul4A-containing ligase complex, we reasoned that VprBP might target Merlin to the Roc1-Cul4A-DDB1 E3 ubiquitin ligase complex.
Adaptor protein VprBP links Merlin to Roc1-Cul4A-DDB1 E3 ligase complex To verify the associations between Merlin and VprBP, DDB1 and other components of the Cul4A ligase complex, we coexpressed Merlin with various components of the Cul4A complex. As shown in Figure 1b , Merlin interacted with VprBP and DDB1. Merlin also coimmunoprecipitated with Roc1 and Cul4A, but not with an unrelated protein Rap80 (Figure 1b) . These data support the notion that Merlin interacts with the Roc1-Cul4A-DDB1-VprBP E3 ubiquitin ligase complex. Since WD40 domain-containing proteins have been shown to interact directly with DDB1 and serve as the substrate-recognition subunits of the Roc1-CUL4-DDB1 ubiquitin ligase, we suspected that VprBP might mediate the interaction between Merlin and the Roc1-Cul4A-DDB1 E3 ligase complex. Indeed, bacterially expressed glutathione S-transferase (GST)-tagged Merlin interacted robustly with VprBP but not with DDB1 (Figure 1c) , indicating that the direct interaction of Merlin and VprBP is required for the association of Merlin with the E3 ubiquitin ligase complex in vivo. Coimmunoprecipitation experiments confirmed the interaction between endogenous Merlin and VprBP (Figure 1d) .
Consistent with the proposed role of VprBP in targeting Merlin to the Roc1-Cul4A-DDB1 complex, VprBP depletion abolished the interaction between Merlin and Roc1-Cul4A-DDB1 complex (Figure 1e ). Phosphorylation of Merlin at Ser518 was previously reported to play an important role in regulating Merlin tumor suppressor activity (Shaw et al., 2001; Alfthan et al., 2004; Jin et al., 2006a) . Interestingly, the interaction between Merlin and VprBP is independent of Ser518 phosphorylation of Merlin (data not shown), suggesting that the Merlin-VprBP interaction might represent a new means for Merlin regulation in vivo.
The very C terminus of VprBP is required for its interaction with Merlin To determine the domain of VprBP that mediates its interaction with Merlin, we used a series of VprBP deletion mutants (Figure 2a) . While neither the LisH nor the WD40 domain was required for this interaction, the Proteins of interest are shown in bold.
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VprBP C terminus encompassing residues 1311-1507 was both necessary and sufficient for the binding of VprBP to Merlin (Figure 2b ). Similarly, we generated a series of Merlin deletion mutants and examined which domains of Merlin might be required for its interaction with VprBP ( Figure 2c ). We found that both the N terminus of Merlin-containing residues 1-225 and a small region in the middle (residues 300-333) were capable of binding to VprBP, indicating that there may be multiple binding sites on Merlin that are involved in its interaction with VprBP ( Figure 2d ). The existence of multiple VprBPbinding regions on Merlin is reminiscent to the interaction between Merlin and PAK1 (Kissil (Figure 3a , left). Preincubation with the proteasome inhibitor MG132 alleviated VprBP-induced Merlin degradation (Figure 3a , right), suggesting that VprBP promotes proteasome-dependent degradation of Merlin. To ascertain that the binding of VprBP to Merlin is required for VprBP-mediated degradation, we examined the effect of a VprBP deletion mutant, VprBP-N (residues 1-1311) that lacks the C-terminal Merlin-binding region. As shown in Figure 3b , overexpression of this VprBP mutant did not markedly alter Merlin expression, establishing that the interaction between VprBP and Merlin is important for Merlin degradation.
To directly demonstrate that VprBP promotes Merlin ubiquitination, we transfected cells with plasmids encoding Flag-tagged Merlin and Myc-tagged ubiquitin, in combination with empty control plasmid or a plasmid encoding hemagglutinin (HA)-VprBP. As shown in Figure 3c , VprBP significantly increased Merlin ubiquitination. Moreover, the addition of MG132 further enhanced Merlin ubiquitination (Figure 3c ). Taken together, these observations suggest that VprBP negatively regulates Merlin by targeting Merlin to the Roc1-Cul4A-DDB1 complex for ubiquitination and degradation.
VprBP is required for Merlin degradation following serum stimulation To further explore the physiological role of the Roc1-Cul4A-DDB1 ubiquitin ligase in Merlin degradation, we examined the steady-state levels of endogenous Merlin with or without VprBP depletion. Two different siRNAs were used to deplete VprBP and both of them led to significant downregulation of endogenous VprBP expression (Figure 4a ). Merlin protein levels were clearly increased in cells transfected with VprBP siRNAs when compared to those transfected with control siRNA (Figure 4a ). In agreement with a role of the Roc1-Cul4A-DDB1 complex in Merlin degradation, depletion of endogenous DDB1 also led to an increase in Merlin protein level (Figure 4a) .
It was previously reported that Merlin protein level is upregulated following serum starvation (Shaw et al., 1998) . Stimulation of serum-starved cells resulted in a rapid disappearance of Merlin protein within 5-15 min (Shaw et al., 1998) . We first examined whether Merlin downregulation following serum stimulation is mediated by the proteasome-dependent degradation pathway. As shown in Figure 4b , the addition of proteasome inhibitor MG132 efficiently blocked Merlin degradation following serum stimulation. Notably, Merlin protein levels did not change following serum addition in VprBP-depleted cells (Figure 4c ), suggesting that serum stimulation-induced Merlin degradation depends on VprBP.
Rac and ERK activities are tightly controlled in the cell. Merlin has been suggested to restrain tumor growth through inhibiting Rac and ERK activities (Shaw et al., 2001; Kissil et al., 2003; Okada et al., 2005; Morrison et al., 2007) . To further substantiate a role of VprBP in Merlin function regulation, we tested whether Rac and ERK activities might be altered in VprBP-depleted cells. As shown in Figure 4d , VprBP depletion, which resulted in Merlin upregulation, was associated with a decrease of Rac1 and ERK activities. Together, these data support that VprBP targets Merlin for degradation following serum stimulation and thus regulates Rac and ERK activities and cell proliferation.
Discussion
The NF2 tumor suppressor gene product, Merlin, is structurally related to the ERM family of proteins that anchor the actin cytoskeleton to specific membrane proteins. Inactivation of the NF2 tumor suppressor gene was first observed in familial schwannomas and other CNS tumors. Notably, mice with heterozygous NF2 VprBP targets Merlin for degradation J Huang and J Chen increases significantly, whereas it is downregulated in response to serum stimulation. However, exactly how Merlin protein level is controlled remains largely unknown.
With the goal to understand the normal cellular function of Merlin and how it is regulated in the cell, we utilized a tandem affinity-purification approach to isolate potential Merlin-interacting proteins. Here, we describe the identification of a novel Merlin interaction protein, the WD40-containing adaptor protein VprBP, which targets Merlin to the Roc1-Cul4A-DDB1 E3 ligase complex for ubiquitination and subsequent proteasome-dependent degradation.
Merlin inhibits tumor formation through its ability to interfere with the activation of Rac and ERK following serum stimulation. In agreement with this model, we showed that VprBP downregulation leads to an increase in Merlin expression and inhibited Rac and ERK activation, indicating that the Roc1-Cul4A-DDB1-VprBP complex may play a role in the control of cell growth and transformation. In summary, our study revealed a previously unknown mechanism for the control of Merlin expression in response to physiological stimuli, which represents an additional layer of Merlin regulation and the control of its tumor suppression function in vivo. 
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Materials and methods
Plasmids
Plasmids encoding human wild-type S518A and S518D mutant of Merlin and wild-type VprBP were kind gifts from Dr KQ Ye (Emory University School of Medicine) and Dr JW Harper (Harvard Medical School), respectively. The full-length or deletion mutants of Merlin, VprBP, Roc1, Cul4A and DDB1 were generated by PCR and subcloned into the pDONR201 vector using Gateway Technology (Invitrogen, San Diego, CA, USA). For transient expression of Merlin, VprBP and their mutants, their corresponding coding sequences in the entry vector were transferred into a Gateway-compatible destination vector, which harbors an N-terminal triple-epitope tag (Sprotein tag, Flag epitope tag and streptavidin-binding peptide tag) or HA or Myc epitope tag. DNA fragments encoding VprBP and Merlin were also generated by PCR and subcloned into pGEX-4T-1 vector (Pharmacia, Uppsala, Sweden) to generate expression constructs of GST-VprBP-C (residues 1311-1507) and GST-Merlin, respectively.
Cell culture, serum starvation and release HeLa and 293T cells were purchased from American Type Culture Collection (Manassas, VA, USA) and maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum at 37 1C in 5% CO 2 (v/v). For serum starvation experiments, subconfluent cells were placed in 0.5% fetal bovine serum for 48 h and then restimulated with normal medium for the indicated time.
siRNA All siRNA duplexes used in this study were purchased from Dharmacon Research (Lafayette, CO, USA). The sequences of DDB1 siRNA1 and siRNA2, VprBP siRNA1 and siRNA2 are respectively 5 0 -ACACTTTGGTGCTCTCTTTUU-3 0 , 5 0 -AGA TCGCGATAATAAAGAAUU-3 0 , 5 0 -GAUGGCGGAUGCU UUGAUAUU-3 0 and 5 0 -UCACAGAGUAUCUUAGAGAU U-3 0 . The sequence of control siRNA is 5 0 -UUCAAUAAAUUC UUGAGGUUU-3 0 . siRNAs were introduced into cells using oligofectamine according to the manufacturer's protocol (Invitrogen).
Antibodies, transfection and immunoprecipitation procedures
Anti-Merlin polyclonal antibodies sc331 and sc332 and anti-ERK1 polyclonal antibody sc-94 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-phospho-ERK1/2 polyclonal antibody 9101S was purchased from Cell , 50 mM NaCl, 50 mM NaF, 100 mM Na3VO4, 1 mM DTT and 50 mg ml À1 PMSF) at 4 1C for 10 min. Crude lysates were cleared by centrifugation at 14 000 r.p.m. and 4 1C for 5 min, and supernatants were incubated with protein A-agarose-conjugated primary antibodies. The immunocomplexes were washed three times with NETN buffer and then subjected to SDS-polyacrylamide gel electrophoresis (PAGE). Western blotting was performed using the antibodies specified in the figure legends. Total cell lysates were obtained by using radioimmunoprecipitation assay buffer (except for immunoprecipitation) (50 mM Tris (pH 8.0), 0.1% SDS, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate).
The establishment of stable cell lines and affinity purification of SFB-tagged protein complexes To establish stably cell lines, 293T cells were transfected with plasmids encoding SFB-tagged proteins. Forty-eight hours after transfection, cells were split at 1:10 ratio and cultured in the medium containing puromycin (2 mg ml À1 ) for 3 weeks. Individual puromycin-resistant colonies were isolated and screened for the expression of tagged proteins by western blotting. For affinity purification of tagged protein complexes, 293T cells stably expressing tagged proteins were collected and lysed with NETN buffer on ice for 20 min. Crude lysates were cleared by centrifugation at 14 000 r.p.m. at 4 1C for 10 min, and supernatants were incubated with 300 ml streptavidinconjugated beads (Amersham, Piscataway, NJ, USA). Beads were washed three times with NETN buffer and then proteins bound to beads were eluted with 1 ml NETN buffer containing 1 mg ml À1 biotin (Sigma). Eluted supernatant was incubated with 80 ml S protein beads (Novagen, Gibbstown, NJ, USA). S beads were washed three times with NETN buffer and proteins were eluted by boiling in sampling buffer and separated by SDS-PAGE. Coomassie blue staining was performed to visualize protein bands, which were excised, digested and subjected to mass spectrometry analysis.
GST pulldown assay Glutathione S-transferase fusion proteins were expressed in Escherichia coli and purified as previously described (Hofer et al., 1994) . Two micrograms of GST-fusion protein or GST alone was immobilized on glutathione-Sepharose 4B beads and incubated with lysates prepared from cells that were transiently transfected with plasmids encoding indicated proteins for 2 h at 4 1C. After washing with NETN buffer, the samples were analysed by western blotting analysis.
